Valuation (43%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 92.43 | 29.91 |
PEG Ratio (TTM) | 0.39 | 5.21 |
P/S Ratio (TTM) | 5.12 | 89.38 |
P/B Ratio (TTM) | 3.16 | 74.29 |
P/FCF Ratio (TTM) | 16.03 | 68.43 |
Price to 5YR AVG Earnings Ratio | N/A | 25.46 |
Price to 5YR AVG FCF Ratio | N/A | 52.56 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.24% | 4.38% |
ROE (TTM) | 3.59% | 8.86% |
Net Profit Margin (TTM) | 0.70% | -16.12% |
ROIC 5YR AVG | N/A | 17.12% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -389.85% | 365.28% | N/A |
Revenue | -0.84% | 20.14% | N/A |
Net Income | -425.69% | 49.82% | N/A |
Cash Flow | -2.08% | 18.25% | N/A |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.20 | 6.01 |
Quick Ratio (TTM) | 5.20 | 5.86 |
D/E Ratio (TTM) | 5.04 | 0.72 |
Interest Coverage (TTM) | 0.74 | 16.24 |
Piotroski F-Score | 2 | 6 |
Altman Z-Score | 2.65 | 5.90 |
LTL to 5YR AVG FCF | N/A | 2.47 |
Shares Outstanding Growth 5YR AVG | N/A | 12.32% |